Kaplan-Meier analysis of 5 independent GEO data sets revealed that high levels of SAP30 were associated with poor overall and metastasis-free survival of patients with breast cancer (Supplemental Figure 1, H–L). This evidence concerns the gene SAP30 and breast carcinoma.